Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN vs APROCITENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBRISENTAN vs APROCITENTAN: Safety Overview

Metric AMBRISENTAN APROCITENTAN
Total FAERS Reports 86,197 10
Deaths Reported 10,291 0
Death Rate 11.9% N/A
Hospitalizations 32,910 3
Average Patient Age 59.5 yrs 61.0 yrs
% Female Patients 76.1% 36.4%
FDA Approval Date Apr 10, 2019 Mar 19, 2024
Manufacturer Sigmapharm Laboratories, LLC Idorsia Pharmaceuticals Ltd
Route ORAL ORAL
Marketing Status Prescription Prescription